News
2026 Taipei–U.S. City Products & Services Showcase
Taipei City, as one of Taiwan’s major economic centers, boasts over 80,000 foreign trade enterprises, accounting for more than one-third of the city’s total businesses, with import trade also representing a significant portion. To provide Taipei’s businesses with diverse sourcing sources, the Taipei City Government is hosting the “2026 Taipei–U.S. City Products & Services Showcase,” collaborating with US state government offices and related industry promotion units to organize various activities to assist Taipei’s businesses in connecting with US companies to expand import sources, deepen supply chain cooperation, strengthen industrial competitiveness, and expand sales in the US market. This year, the program will utilize four types of activities—”Product and Service Exhibitions,” “B2B Negotiations and Industry Exchanges,” “Thematic Forums,” and “Industry Briefings and Service Chain Seminars”—to help Taiwanese businesses grasp the pulse of Taiwan-US economic and trade cooperation and key market opportunities.
Event Details
Date: July 30–31, 2026
Time: 10:00 AM – 5:30 PM
Venue: 2F, NTUH International Convention Center
(No. 2, Xuzhou Road, Zhongzheng District, Taipei City, Taiwan)
September 4th, 2025 /Taipei Investment Seminar” Debuts in Tokyo on 29 August 2025 - Building an International Investment-Promotion Brand under the Theme “AI-Driven × Net-Zero Partnerships
To showcase and promote Taipei’s investment environment, broaden outreach to prospective investors, and create a platform for industry exchange, the Taipei City Government’s Department of Economic Development will host the first overseas Taipei Investment Seminar on 29 August 2025 at the Hotel Okura Tokyo. The event invites Japanese enterprises to participate. The city’s Invest Taipei Office (ITO) will present Taipei’s investment opportunities and latest proposals, while Marubeni Corporation will share its growth experience investing in Taipei and its future vision. Through this international exchange, the city aims to highlight Taipei’s robust industrial base and dynamic innovation ecosystem, strengthening its distinctive investment appeal.
Serving as an one-stop window service for foreign investors, ITO provides end-to-end, project-based support—from company formation, site selection, talent visas, regulatory and tax advisory, R&D grants, and PoC testing to public–private collaboration—helping companies evaluate faster, pilot faster, and land faster in Taipei. Looking ahead, the city will continue to expand the global brand impact of Invest Taipei through internationally oriented, single-window delivery, with a strategic focus on “AI × Net Zero.” Taipei seeks to deepen cooperation with Japanese enterprises in R&D, decarbonization, and digital transformation, working together to chart the next decade of growth.
July 14th, 2025 / Taiwan Medical & Biotech Talent Market Report
Taiwan’s medical and biotech industries are expanding rapidly, driving strong demand for talent and dynamic market changes. The talent needs in Taiwan’s biotech and pharmaceutical industry are concentrated in several core functional areas, including Commercial (sales & marketing), Medical Affairs, Market Access, Clinical Operations, Regulatory Affairs, as well as clinical development roles like Biostatistics and Data Management.
In digital health, Taiwan can leverage its strong ICT industry to integrate tech with healthcare (for example, developing smart hospitals and health management platforms), and talent development in this area can benefit from the country’s solid IT talent base. However, there is still a dearth of professionals adept in both healthcare and technology, calling for enhanced biomedical informatics programs and industry-academic collaboration. In precision medicine, Taiwan has a favorable clinical trial environment and rich biobank resources to invest in cancer genomics and targeted therapy studies, but it urgently needs specialists in bioinformatics, clinical genetics, and related areas. In the rare diseases field, Taiwan has introduced regulatory incentives for orphan drugs, encouraging companies to develop and bring in treatments for rare conditions. Consequently, demand will grow for talent well-versed in global orphan drug regulations and clinical trial design for small patient populations.
July 14th, 2025 / Powering Taiwan’s AI Future: Navigating Grid Challenges with Smarter Energy Solutions
Taiwan is entering a new phase of technological growth, driven by the rapid rise of artificial intelligence (AI) data centers. These high-performance facilities are essential for powering cloud services, generative AI models, and big data processing—but they come with major energy demands. Over the next three years, this surge in electricity use will test the limits of Taiwan’s power grid and challenge its path to a more sustainable energy future.
Invest Taipei Investment Promotion Brand Video
Links
